Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
Jennifer S. Lees(NHS Greater Glasgow and Clyde), Patrick B. Mark(Queen Elizabeth University Hospital), Paul Welsh, Stuart R. Gray(University of Glasgow), Jason M. R. Gill(University of Glasgow), Jill P. Pell(University of Glasgow), Daniel Mackay(University of Glasgow), Donald M. Lyall(University of Glasgow), Carlos Celis‐Morales(Catholic University of the Maule), Naveed Sattar(University of Glasgow), Claire Welsh(NHS England), John G.F. Cleland(University of Glasgow), James Lewsey(University of Glasgow), Pardeep S. Jhund(Copenhagen University Hospital)
Cited by 312
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k